Patent details

EP3508204 Title: QUINAZOLIN-8-YL DERIVATIVES FOR USE IN METHODS OF TREATING MELANOMA, NON-SMALL CELL LUNG CANCER, THYROID CANCER, OVARIAN CANCER, OR COLON CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3508204
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19157227.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
22/08/2014
Grant date:
11/02/2026
EP Publication Date:
10/07/2019
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/02/2026
EP B1 Publication Date:
11/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/08/2034
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/02/2026
 
 

 

Name:
Neupharma, Inc.
Address:
1175 Chess Drive Suite 206, Foster City, CA 94404, United States of America (US)

Inventor

1

Name:
QIAN, Xiangping
Address:
Foster City, CA 94404, United States of America (US)

2

Name:
ZHU, Yong-Liang
Address:
Fremont, CA 94539, United States of America (US)

Priority

1

Priority Patent Number:
201462000946 P
Priority Date:
20/05/2014
Priority Country:
United States of America (US)

2

Priority Patent Number:
201361900283 P
Priority Date:
05/11/2013
Priority Country:
United States of America (US)

3

Priority Patent Number:
201361869596 P
Priority Date:
23/08/2013
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/519; C07D 471/04;

Publication

Bulletin

Bulletin Heading:
EP2
Journal edition number:
06/26
Publication date:
11/02/2026
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202608
Publication date:
18/02/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202607
Publication date:
11/02/2026
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/08/2026
Annual Fee Number:
13
Annual Fee Amount:
700 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type